These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 11912159)

  • 1. Nuclear factor kappaB dependency of platelet-activating factor-induced angiogenesis.
    Ko HM; Seo KH; Han SJ; Ahn KY; Choi IH; Koh GY; Lee HK; Ra MS; Im SY
    Cancer Res; 2002 Mar; 62(6):1809-14. PubMed ID: 11912159
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Involvement of matrix metalloproteinase-9 in platelet-activating factor-induced angiogenesis.
    Ko HM; Park YM; Jung B; Kim HA; Choi JH; Park SJ; Lee HK; Im SY
    FEBS Lett; 2005 Apr; 579(11):2369-75. PubMed ID: 15848174
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Essential role for platelet-activating factor-induced NF-kappaB activation in macrophage-derived angiogenesis.
    Seo KH; Ko HM; Choi JH; Jung HH; Chun YH; Choi IW; Lee HK; Im SY
    Eur J Immunol; 2004 Aug; 34(8):2129-37. PubMed ID: 15259010
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nitric oxide mediates angiogenesis induced in vivo by platelet-activating factor and tumor necrosis factor-alpha.
    Montrucchio G; Lupia E; de Martino A; Battaglia E; Arese M; Tizzani A; Bussolino F; Camussi G
    Am J Pathol; 1997 Aug; 151(2):557-63. PubMed ID: 9250168
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Platelet-activating factor (PAF) induces corneal neovascularization and upregulates VEGF expression in endothelial cells.
    Ma X; Ottino P; Bazan HE; Bazan NG
    Invest Ophthalmol Vis Sci; 2004 Sep; 45(9):2915-21. PubMed ID: 15326102
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vascular endothelial growth factor, interleukin 8, platelet-derived endothelial cell growth factor, and basic fibroblast growth factor promote angiogenesis and metastasis in human melanoma xenografts.
    Rofstad EK; Halsør EF
    Cancer Res; 2000 Sep; 60(17):4932-8. PubMed ID: 10987309
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blockade of EphA receptor tyrosine kinase activation inhibits vascular endothelial cell growth factor-induced angiogenesis.
    Cheng N; Brantley DM; Liu H; Lin Q; Enriquez M; Gale N; Yancopoulos G; Cerretti DP; Daniel TO; Chen J
    Mol Cancer Res; 2002 Nov; 1(1):2-11. PubMed ID: 12496364
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Platelet-activating factor directly stimulates in vitro migration of endothelial cells and promotes in vivo angiogenesis by a heparin-dependent mechanism.
    Camussi G; Montrucchio G; Lupia E; De Martino A; Perona L; Arese M; Vercellone A; Toniolo A; Bussolino F
    J Immunol; 1995 Jun; 154(12):6492-501. PubMed ID: 7539022
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Significance of vascular endothelial cell growth factor up-regulation mediated via a chymase-angiotensin-dependent pathway during angiogenesis in hamster sponge granulomas.
    Katada J; Muramatsu M; Hayashi I; Tsutsumi M; Konishi Y; Majima M
    J Pharmacol Exp Ther; 2002 Sep; 302(3):949-56. PubMed ID: 12183651
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The homeobox gene Gax inhibits angiogenesis through inhibition of nuclear factor-kappaB-dependent endothelial cell gene expression.
    Patel S; Leal AD; Gorski DH
    Cancer Res; 2005 Feb; 65(4):1414-24. PubMed ID: 15735029
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of sphingosine-1-phosphate- and vascular endothelial growth factor-induced endothelial cell chemotaxis by red grape skin polyphenols correlates with a decrease in early platelet-activating factor synthesis.
    Barthomeuf C; Lamy S; Blanchette M; Boivin D; Gingras D; Béliveau R
    Free Radic Biol Med; 2006 Feb; 40(4):581-90. PubMed ID: 16458188
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CEP-7055: a novel, orally active pan inhibitor of vascular endothelial growth factor receptor tyrosine kinases with potent antiangiogenic activity and antitumor efficacy in preclinical models.
    Ruggeri B; Singh J; Gingrich D; Angeles T; Albom M; Yang S; Chang H; Robinson C; Hunter K; Dobrzanski P; Jones-Bolin S; Pritchard S; Aimone L; Klein-Szanto A; Herbert JM; Bono F; Schaeffer P; Casellas P; Bourie B; Pili R; Isaacs J; Ator M; Hudkins R; Vaught J; Mallamo J; Dionne C
    Cancer Res; 2003 Sep; 63(18):5978-91. PubMed ID: 14522925
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of angiogenic factors vascular endothelial growth factor and interleukin-8/CXCL8 is highly responsive to ambient glutamine availability: role of nuclear factor-kappaB and activating protein-1.
    Bobrovnikova-Marjon EV; Marjon PL; Barbash O; Vander Jagt DL; Abcouwer SF
    Cancer Res; 2004 Jul; 64(14):4858-69. PubMed ID: 15256456
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Correlation of angiogenesis with expression of vascular endothelial growth factor and its receptors in lung carcinoma].
    Zhang G; Zhao M; Xu M; Yang Y; Wang M; Yang C
    Zhonghua Jie He He Hu Xi Za Zhi; 2002 Feb; 25(2):89-93. PubMed ID: 11953105
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Platelet-activating factor-induced NF-kappaB activation enhances VEGF expression through a decrease in p53 activity.
    Ko HM; Jung HH; Seo KH; Kang YR; Kim HA; Park SJ; Lee HK; Im SY
    FEBS Lett; 2006 May; 580(13):3006-12. PubMed ID: 16684540
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro and in vivo angiogenesis in PC12 pheochromocytoma cells is mediated by vascular endothelial growth factor.
    Middeke M; Hoffmann S; Hassan I; Wunderlich A; Hofbauer LC; Zielke A
    Exp Clin Endocrinol Diabetes; 2002 Nov; 110(8):386-92. PubMed ID: 12518248
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Platelet-activating factor enhances vascular endothelial growth factor-induced endothelial cell motility and neoangiogenesis in a murine matrigel model.
    Montrucchio G; Lupia E; Battaglia E; Del Sorbo L; Boccellino M; Biancone L; Emanuelli G; Camussi G
    Arterioscler Thromb Vasc Biol; 2000 Jan; 20(1):80-8. PubMed ID: 10634803
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of fractalkine/CX3CR1 by vascular endothelial cells induces angiogenesis through VEGF-A/KDR and reverses hindlimb ischaemia.
    Ryu J; Lee CW; Hong KH; Shin JA; Lim SH; Park CS; Shim J; Nam KB; Choi KJ; Kim YH; Han KH
    Cardiovasc Res; 2008 May; 78(2):333-40. PubMed ID: 18006432
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relative effects of VEGF-A and VEGF-C on endothelial cell proliferation, migration and PAF synthesis: Role of neuropilin-1.
    Bernatchez PN; Rollin S; Soker S; Sirois MG
    J Cell Biochem; 2002; 85(3):629-39. PubMed ID: 11968003
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor growth, angiogenesis and inflammation in mice lacking receptors for platelet activating factor (PAF).
    Ferreira MA; Barcelos LS; Teixeira MM; Bakhle YS; Andrade SP
    Life Sci; 2007 Jun; 81(3):210-7. PubMed ID: 17588613
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.